BNF for Children (BNFC) 2018-2019

Ensure®Plus Juce
(Abbott Laboratories
Ltd)

Liquid (sip feed)

per 100 mL

638 kJ

( 150 kcal)

4. 8 g

whey protein

isolate

32. 7 g

(sugars 9. 4 g)

Nil Nil Gluten-free

Residual lactose

Non-milk taste

Borderline substances standard

ACBS indications p. 1012

Ensure Plus Juce liquid: assorted

880 ml = no price available; apple,

fruit punch, lemon & lime, orange,

peach, strawberry 220 ml = £ 1. 97

Fortijuce®
(Nutricia Ltd)

Liquid (sip feed)

per 100 mL

640 kJ

( 150 kcal)

4. 0 g

cows’milk

33. 5 g

(sugars 13. 1 g)

Nil Nil Gluten-free

Residual lactose

Non-milk taste

Borderline substances standard

ACBS indications p. 1012

Not suitable for child under 3 years

Fortijuce Starter Pack liquid:

assorted 800 ml = £ 8. 08 ; Fortijuce

liquid: apple, blackcurrant, forest

fruits, lemon, orange, strawberry,

tropical 200 ml = £ 2. 02. Sugar

content varies with flavour

Fresubin®Jucy Drink
(Fresenius Kabi Ltd)

Liquid (sip feed)

per 100 mL

630 kJ

( 150 kcal)

4 g

whey protein

33. 5 g

(sugars 8 g)

Nil Nil Gluten-free

Residual lactose

Borderline substances standard

ACBS indications p. 1012 ; also CAPD,

haemodialysis

Fresubin Jucy drink: blackcurrant,

cherry, pineapple 200 ml =; 800 ml

=£ 8. 04 ; orange 200 ml =; 800 ml =

£ 8. 04 ; apple 400 ml =; 800 ml =

£ 8. 04

Paediasure®Plus Juce
(Abbott Laboratories
Ltd)

Liquid (sip feed)

per 100 mL

638 kJ

( 150 kcal)

4. 2 g

cows’milk

33. 3 g

(sugars 9. 4 g)

Nil Nil Gluten-free

Residual lactose

Non-milk taste

Nutritional supplement in child

1 – 10 years, body-weight 8 – 30 kg

with disease-related malnutrition and,

or growth failure

PaediaSure Plus Juce liquid: apple,

very berry 200 ml = £ 3. 36

Nutritional supplements: 5 g (or more) protein/100 mL

Nutritional supplements: 1.5 kcal/mL and 5 g (or more) protein/100 mL
Not suitable for use in child under 1 year; use with caution in child 1–5 years unless otherwise stated.

Product Formulation Energy Protein Carbohydrate Fat Fibre Special Characteristics ACBS Indications Presentation & Flavour

Altraplen®Protein
(Nualtra Ltd)

Liquid (sip feed)

per 100 mL

632 kJ

( 150 kcal)

10 g

cows’milk

soya protein

15 g

(sugars 4. 6 g)

5. 6 g Nil Gluten-free

Residual lactose

Borderline substances standard

ACBS indications p. 1012

Not suitable for child under 3 years;

use with caution in child 3 – 6 years

Altraplen Protein liquid: strawberry

200 ml =; 800 ml = £ 6. 36 ; vanilla

200 ml =; 800 ml = £ 6. 36

Ensure®Plus
Commence
(Abbott Laboratories
Ltd)

Starter pack ( 5 – 10 days supply), contains: Ensure®Plus Commence (various flavours), 1 pack ( 106220 ml) = £ 11. 10

Ensure®Plus Fibre
(Abbott Laboratories
Ltd)

Liquid (sip or tube

feed)

per 100 mL

652 kJ

( 155 kcal)

6. 25 g

cows’milk

soya protein

isolate

20. 2 g

(sugars 5. 5 g)

4. 92 g 2. 5 g Gluten-free

Residual lactose

Borderline substances standard

ACBS indications p. 1012 ; also CAPD,

haemodialysis.

Ensure Plus Fibre liquid: banana,

chocolate, raspberry, strawberry,

vanilla 200 ml = £ 2. 07. Nutritional

values vary with flavour—consult

product literature

Ensure®Plus
Milkshake style
(Abbott Laboratories
Ltd)

Liquid (sip or tube

feed)

per 100 mL

632 kJ

( 150 kcal)

6. 25 g

cows’milk

soya protein

isolate

20. 2 g

(sugars 6. 89 g)

4. 92 g Nil Gluten-free

Residual lactose

Borderline substances standard

ACBS indications p. 1012 ; also CAPD,

haemodialysis

Ensure Plus milkshake style liquid:

banana, chocolate, coffee, fruits of

the forest, neutral, peach, raspberry,

strawberry, vanilla 200 ml = £ 1. 11

Nutritional values vary with flavour—

consult product literature

Ensure®Plus Savoury
(Abbott Laboratories
Ltd)

Liquid (sip or tube

feed)

per 100 mL

632 kJ

( 150 kcal)

6. 25 g

cows’milk

soy protein

isolate

20. 2 g

(sugars 1. 13 g)

4. 92 g Nil Gluten-free

Residual lactose

Borderline substances standard

ACBS indications p. 1012 ; also CAPD,

haemodialysis.

Ensure Plus savoury liquid: chicken,

200 ml = £ 1. 11

BNFC

2018

– 2019

Nutritional supplements (non-disease speci

fi

c)

1023

Borderline substances|Appendix 2

A2